Final diagnosis and patient disposition following equivocal results on 2-mSv CT vs. conventional-dose CT in adolescents and young adults with suspected appendicitis: a post hoc analysis of large pragmatic randomized trial data

2021 ◽  
Author(s):  
Jungheum Cho ◽  
◽  
Seungjae Lee ◽  
Hooney Daniel Min ◽  
Hae Young Kim ◽  
...  
Keyword(s):  
Young Adults ◽  
Randomized Trial ◽  
Final Diagnosis ◽  
Trial Data ◽  
Adolescents And Young Adults ◽  
Suspected Appendicitis ◽  
Post Hoc Analysis ◽  
Patient Disposition ◽  
Conventional Dose ◽  
Post Hoc

scholarly journals MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies

2020 ◽  
Vol 9 (3) ◽  
pp. 641-656
Author(s):  
Johannes Beeslaar ◽  
Judith Absalon ◽  
Annaliesa S. Anderson ◽  
Joseph J. Eiden ◽  
Paul Balmer ◽  
...  
Keyword(s):  
Young Adults ◽  
Adolescents And Young Adults ◽  
Phase 3 ◽  
Two Phase ◽  
Post Hoc Analysis ◽  
Post Hoc

Cytochrome c in patients undergoing coronary artery bypass grafting: A post hoc analysis of a randomized trial

2017 ◽  
Vol 42 ◽  
pp. 248-254
Author(s):  
Lars W. Andersen ◽  
Xiaowen Liu ◽  
Sophia Montissol ◽  
Mathias J. Holmberg ◽  
Bjørn K. Fabian-Jessing ◽  
...  
Keyword(s):  
Coronary Artery ◽  
Coronary Artery Bypass Grafting ◽  
Cytochrome C ◽  
Randomized Trial ◽  
Coronary Artery Bypass ◽  
Artery Bypass ◽  
Bypass Grafting ◽  
Artery Bypass Grafting ◽  
Post Hoc Analysis ◽  
Post Hoc

scholarly journals Randomized Trial on the Safety, Tolerability, and Immunogenicity of MenACWY-CRM, an Investigational Quadrivalent Meningococcal Glycoconjugate Vaccine, Administered Concomitantly with a Combined Tetanus, Reduced Diphtheria, and Acellular Pertussis Vaccine in Adolescents and Young Adults

2010 ◽  
Vol 17 (4) ◽  
pp. 537-544 ◽  
Author(s):  
Roberto Gasparini ◽  
Michele Conversano ◽  
Gianni Bona ◽  
Giovanni Gabutti ◽  
Alessandra Anemona ◽  
...  
Keyword(s):  
Young Adults ◽  
Adverse Events ◽  
Randomized Trial ◽  
Conjugate Vaccine ◽  
Antibody Responses ◽  
Adolescents And Young Adults ◽  
Tdap Vaccine ◽  
Glycoconjugate Vaccine ◽  
Clinically Significant ◽  
Quadrivalent Meningococcal Conjugate Vaccine

ABSTRACT This study evaluated the safety, tolerability, and immunogenicity of an investigational quadrivalent meningococcal conjugate vaccine, MenACWY-CRM, when administered concomitantly with a combined tetanus, reduced diphtheria, and acellular pertussis (Tdap) vaccine, in subjects aged 11 to 25 years. Subjects received either MenACWY-CRM and Tdap, MenACWY-CRM and saline placebo, or Tdap and saline placebo. No significant increase in reactogenicity and no clinically significant vaccine-related adverse events (AEs) occurred when MenACWY-CRM and Tdap were administered concomitantly. Similar immunogenic responses to diphtheria, tetanus, and meningococcal (serogroups A, C, W-135, and Y) antigens were observed, regardless of concomitant vaccine administration. Antipertussis antibody responses were comparable between vaccine groups for filamentous hemagglutinin and were slightly lower, although not clinically significantly, for pertussis toxoid and pertactin when the two vaccines were administered concomitantly. These results indicate that the investigational MenACWY-CRM vaccine is well tolerated and immunogenic and that it can be coadministered with Tdap to adolescents and young adults.

Sign in / Sign up

Export Citation Format

Share Document